Caribou Biosciences, Inc. (CRBU) Operating income 2019–2025
Caribou Biosciences, Inc. (CRBU) annual operating income history from SEC filings — each fiscal year as reported.
-$148.3MFY2025 · since FY2019: -$34.3M → -$148.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$148.3M | +11.0% |
| FY2024 | -$166.6M | -43.6% |
| FY2023 | -$116.1M | -9.1% |
| FY2022 | -$106.4M | -58.9% |
| FY2021 | -$67.0M | -85.4% |
| FY2020 | -$36.1M | -5.3% |
| FY2019 | -$34.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBU financial trends
CRBU RevenueCRBU Net incomeCRBU Net marginCRBU Gross profitCRBU Gross marginCRBU Operating marginCRBU Operating cash flowCRBU Free cash flowCRBU Capital expendituresCRBU Return on equityCRBU Stock buybacksCRBU Dividends paidCRBU Total assetsCRBU Total liabilitiesCRBU Shareholders’ equityCRBU overview →